NY State Senate Bill 2015-S5662A

Senate Bill S5662A

2015-2016 Legislative Session

Provides that no antidepressant or anti-anxiety medication which has an increased risk of suicidal behavior in individuals shall be dispensed without consultation and other information to outpatients

download bill text pdf

Archive: Last Bill Status - In Senate Committee Mental Health And Developmental Disabilities Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 06, 2016	referred to mental health and developmental disabilities
Nov 18, 2015	print number 5662a
Nov 18, 2015	amend (t) and recommit to mental health and developmental disabilities
May 26, 2015	referred to mental health and developmental disabilities

Bill Amendments

Original

A (Active)

2015-S5662 - Details

Current Committee:: Senate Mental Health And Developmental Disabilities
Law Section:: Mental Hygiene Law
Laws Affected:: Add §7.47, Ment Hyg L
Versions Introduced in Other Legislative Sessions:: 2013-2014: S7383
2017-2018: S2423

2015-S5662 - Summary

Provides that no antidepressant or anti-anxiety medication which has an increased risk of suicidal behavior in individuals shall be dispensed without consultation and other information to certain persons receiving outpatient services.

2015-S5662 - Sponsor Memo

2015-S5662 - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  5662

                       2015-2016 Regular Sessions

                            I N  S E N A T E

                              May 26, 2015
                               ___________

Introduced  by Sen. HAMILTON -- read twice and ordered printed, and when
  printed to be committed to the Committee on Mental Health and Develop-
  mental Disabilities

AN ACT to amend the mental hygiene law, in relation to the  prescription
  of  antidepressant and antianxiety medications which have an increased
  risk of suicidal behavior

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  The mental hygiene law is amended by adding a new section
7.47 to read as follows:
S 7.47 ANTIDEPRESSANT AND ANTIANXIETY MEDICATIONS; SUICIDE RISK.
  (A) WHEN A PATIENT RECEIVES A PRESCRIPTION FOR  AN  ANTIDEPRESSANT  OR
ANTIANXIETY  MEDICATION IN AN OUTPATIENT SETTING, AND THE MEDICATION HAS
AN INCREASED RISK OF SUICIDALITY, THE OFFICE SHALL IDENTIFY SUCH MEDICA-
TIONS AND SHALL REQUIRE PHARMACISTS IN THE COURSE OF CONSULTATION,  UPON
THE  FIRST  TIME DISPENSING OF THE MEDICATION TO THE PATIENT, TO PROVIDE
THE FOLLOWING:
  (1) THE TOLL-FREE SUICIDE PREVENTION LIFELINE TELEPHONE NUMBER  ESTAB-
LISHED BY THE OFFICE;
  (2)  THE  SUICIDE  PREVENTION LIFELINE WEBSITE INTERNET ADDRESS ESTAB-
LISHED BY THE OFFICE; AND
  (3) A PAMPHLET PUBLISHED BY THE  OFFICE  SETTING  FORTH  ALL  RELEVANT
INFORMATION  REGARDING  THE  INCREASED RISK OF SUICIDE AND SUICIDAL SIDE
EFFECTS ASSOCIATED WITH THE MEDICATION, INCLUDING, BUT NOT  LIMITED  TO,
INFORMATION  SETTING  FORTH  THE  WARNING  SIGNS  ASSOCIATED  WITH  SUCH
SUICIDAL BEHAVIOR AND ANY OTHER INFORMATION THE OFFICE DEEMS RELEVANT.
  (B) ANY CONSULTATION REQUIRED BY SUBDIVISION (A) OF THIS SECTION  WITH
A  PERSON  UNDER  SEVENTEEN  YEARS OF AGE SHALL REQUIRE THAT A PARENT OR
LEGAL GUARDIAN OF SUCH PERSON BE IN ATTENDANCE DURING SUCH CONSULTATION.
  (C) NO MEDICATION DESCRIBED IN SUBDIVISION (A) OF THIS  SECTION  SHALL
BE  DISPENSED,  DISPERSED OR OTHERWISE GIVEN TO A PERSON UNDER SEVENTEEN

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD06299-02-5

S. 5662                             2

YEARS OF AGE UNLESS A PARENT OR LEGAL GUARDIAN  OF  SUCH  PERSON  IS  IN
ATTENDANCE.
  (D)  THE OFFICE IS AUTHORIZED AND DIRECTED TO PROMULGATE ANY RULES AND
REGULATIONS AND PREPARE PAMPHLETS NECESSARY TO IMPLEMENT THE  PROVISIONS
OF THIS SECTION.
  S  2.  This  act shall take effect on the ninetieth day after it shall
have become a law; provided, however, that  effective  immediately,  the
addition,  amendment  and/or  repeal of any rule or regulation necessary
for the implementation of this act on its effective date  is  authorized
to be made and completed on or before such date.

co-Sponsors

2015-S5662A (ACTIVE) - Details

Current Committee:: Senate Mental Health And Developmental Disabilities
Law Section:: Mental Hygiene Law
Laws Affected:: Add §7.47, Ment Hyg L
Versions Introduced in Other Legislative Sessions:: 2013-2014: S7383
2017-2018: S2423

2015-S5662A (ACTIVE) - Summary

2015-S5662A (ACTIVE) - Sponsor Memo

                                 BILL NUMBER:  S5662A

 TITLE OF BILL :

An act to amend the mental hygiene law, in relation to the
prescription of antidepressant and anti-anxiety medications which have
an increased risk of suicidal behavior

 PURPOSE :

Provides that no antidepressant or anti-anxiety medication prescribed
in an outpatient setting which has an increased risk of suicidality
shall be dispensed for a first-time patient, before having first had a
consultation with supporting educational literature

 SUMMARY OF PROVISIONS :

Section 1 is amended by adding a new section 7.45, to include several
instructions regarding the dispensing of an antidepressant or
anti-anxiety medication with suicidal tendencies as an undesired side
effect. During the required consultation, pharmacists will provide
literature with the toll-free suicide prevention telephone number,
suicide prevention website and an information pamphlet drafted by the
Department of Mental Health. Other provisions include: Requirement of
parent or guardian if prescribed patient is under 17 and permission to
the Department to regulate and prepare all material.

Section 2: Effective Date.

 JUSTIFICATION :

Each year the Centers for Disease Control and Prevention collect data
regarding mortality in the United States, including deaths by suicide.
In 2010, 38,364 suicides were reported.  In that year, someone in the
country died by suicide ever 13.7 minutes.  Suicidal tendencies are
increasing as a potential side effect in many prescriptions -- those
that can cause an individual's personality and physical well being to
negatively change.

By educating the patient as well as kin upon prescription pickup, this
legislation aims to save the lives of individuals who perhaps
otherwise would have taken their life.

 LEGISLATIVE HISTORY :

S 7383-A 06/10/14 Mental Hygiene Law

 FISCAL IMPLICATIONS :

None.

 EFFECTIVE DATE :
This act shall take effect on the 90th day after it shall have become
a law.

2015-S5662A (ACTIVE) - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 5662--A

                       2015-2016 Regular Sessions

                            I N  S E N A T E

                              May 26, 2015
                               ___________

Introduced  by Sen. HAMILTON -- read twice and ordered printed, and when
  printed to be committed to the Committee on Mental Health and Develop-
  mental Disabilities -- committee  discharged,  bill  amended,  ordered
  reprinted as amended and recommitted to said committee

AN  ACT to amend the mental hygiene law, in relation to the prescription
  of antidepressant and anti-anxiety medications which have an increased
  risk of suicidal behavior

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  The mental hygiene law is amended by adding a new section
7.47 to read as follows:
S 7.47 ANTIDEPRESSANT AND ANTI-ANXIETY MEDICATIONS; SUICIDE RISK.
  (A) WHEN A PATIENT RECEIVES A PRESCRIPTION FOR  AN  ANTIDEPRESSANT  OR
ANTI-ANXIETY MEDICATION IN AN OUTPATIENT SETTING, AND THE MEDICATION HAS
AN INCREASED RISK OF SUICIDALITY, THE OFFICE SHALL IDENTIFY SUCH MEDICA-
TIONS  AND SHALL REQUIRE PHARMACISTS IN THE COURSE OF CONSULTATION, UPON
THE FIRST TIME DISPENSING OF THE MEDICATION TO THE PATIENT,  TO  PROVIDE
THE FOLLOWING:
  (1)  THE TOLL-FREE SUICIDE PREVENTION LIFELINE TELEPHONE NUMBER ESTAB-
LISHED BY THE OFFICE;
  (2) THE SUICIDE PREVENTION LIFELINE WEBSITE  INTERNET  ADDRESS  ESTAB-
LISHED BY THE OFFICE; AND
  (3)  A  PAMPHLET  PUBLISHED  BY  THE OFFICE SETTING FORTH ALL RELEVANT
INFORMATION REGARDING THE INCREASED RISK OF SUICIDE  AND  SUICIDAL  SIDE
EFFECTS  ASSOCIATED  WITH THE MEDICATION, INCLUDING, BUT NOT LIMITED TO,
INFORMATION  SETTING  FORTH  THE  WARNING  SIGNS  ASSOCIATED  WITH  SUCH
SUICIDAL BEHAVIOR AND ANY OTHER INFORMATION THE OFFICE DEEMS RELEVANT.
  (B)  ANY CONSULTATION REQUIRED BY SUBDIVISION (A) OF THIS SECTION WITH
A PERSON UNDER SEVENTEEN YEARS OF AGE SHALL REQUIRE  THAT  A  PARENT  OR
LEGAL GUARDIAN OF SUCH PERSON BE IN ATTENDANCE DURING SUCH CONSULTATION.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD06299-03-5

S. 5662--A                          2

  (C)  NO  MEDICATION DESCRIBED IN SUBDIVISION (A) OF THIS SECTION SHALL
BE DISPENSED, DISPERSED OR OTHERWISE GIVEN TO A PERSON  UNDER  SEVENTEEN
YEARS  OF  AGE  UNLESS  A  PARENT OR LEGAL GUARDIAN OF SUCH PERSON IS IN
ATTENDANCE DURING THE CONSULTATION.
  (D)  THE OFFICE IS AUTHORIZED AND DIRECTED TO PROMULGATE ANY RULES AND
REGULATIONS AND PREPARE PAMPHLETS NECESSARY TO IMPLEMENT THE  PROVISIONS
OF THIS SECTION.
  S  2.  This  act shall take effect on the ninetieth day after it shall
have become a law; provided, however, that  effective  immediately,  the
addition,  amendment  and/or  repeal of any rule or regulation necessary
for the implementation of this act on its effective date  is  authorized
to be made and completed on or before such date.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.